Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC DNQX (FG 9041) | 2379-57-9 | C8H4N4O6 | 100 MG
SDP

Catalog No. 5000375117
Encompass_Preferred

DNQX (FG 9041) is a quinoxaline derivative that functions as a selective, potent competitive non-NMDA glutamate receptor antagonist. It exhibits IC50 values of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors, respectively. This compound is known to selectively depolarize thalamic reticular nucleus (TRN) neurons.

  • Selective, potent competitive non-NMDA glutamate receptor antagonist
  • Exhibits IC50s of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors
  • Selectively depolarizes thalamic reticular nucleus (TRN) neurons
  • Purity of 99.67%
  • Molecular weight of 252.14
  • Appears as a white to off-white solid

Catalog No. 50-003-75117 Supplier Medchemexpress LLC Supplier No. HY15067100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DNQX (FG 9041) is a quinoxaline derivative that functions as a selective, potent competitive non-NMDA glutamate receptor antagonist. It exhibits IC50 values of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors, respectively. This compound is known to selectively depolarize thalamic reticular nucleus (TRN) neurons.

  • Selective, potent competitive non-NMDA glutamate receptor antagonist
  • Exhibits IC50s of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors
  • Selectively depolarizes thalamic reticular nucleus (TRN) neurons
  • Purity of 99.67%
  • Molecular weight of 252.14
  • Appears as a white to off-white solid

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.